Natixis Advisors, L.P. Repligen Corp Transaction History

Natixis Advisors, L.P.

$68.5 Billion
Q3 2025

A detailed history of Natixis Advisors, L.P. transactions in Repligen Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 38,329 shares of RGEN stock, worth $5.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

38,329

Previous 28,314 35.37%

Holding current value

$5.84 Million

Previous $3.52 Million 45.46%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$111.43 - $134.0 $1.12 Million - $1.34 Million	10,015 Added 35.37%	38,329 $5.12 Million
Q2 2025 Aug 13, 2025	SELL	$108.89 - $145.23 $1.86 Million - $2.49 Million	-17,114 Reduced 37.67%	28,314 $3.52 Million
Q1 2025 May 08, 2025	BUY	$127.24 - $174.24 $141,363 - $193,580	1,111 Added 2.51%	45,428 $5.78 Million
Q4 2024 Feb 10, 2025	BUY	$123.41 - $160.92 $1.32 Million - $1.72 Million	10,692 Added 31.8%	44,317 $6.38 Million
Q3 2024 Nov 06, 2024	BUY	$119.79 - $167.35 $1.41 Million - $1.96 Million	11,731 Added 53.58%	33,625 $5 Million

Q2 2024 Aug 01, 2024	SELL	$120.0 - $182.95 $1.89 Million - $2.88 Million	-15,718 Reduced 41.79%	21,894 $2.76 Million
Q1 2024 Apr 25, 2024	BUY	$170.78 - $208.42 $151,140 - $184,451	885 Added 2.41%	37,612 $6.92 Million
Q4 2023 Feb 06, 2024	BUY	$114.17 - $185.35 $901,029 - $1.46 Million	7,892 Added 27.37%	36,727 $6.6 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $338,068 - $429,978	2,436 Added 9.23%	28,835 $4.59 Million
Q2 2023 Aug 15, 2023	BUY	$138.42 - $180.31 $1.95 Million - $2.54 Million	14,078 Added 114.26%	26,399 $3.73 Million
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $3.7 Million - $4.75 Million	-23,984 Reduced 66.06%	12,321 $2.07 Million
Q4 2022 Jan 27, 2023	SELL	$162.42 - $220.56 $372,591 - $505,964	-2,294 Reduced 5.94%	36,305 $6.15 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $353,405 - $564,430	2,203 Added 6.05%	38,599 $7.22 Million
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $23.3 Million - $31.1 Million	-165,311 Reduced 81.96%	36,396 $5.91 Million
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $14.7 Million - $23.5 Million	91,047 Added 82.28%	201,707 $37.9 Million
Q4 2021 Feb 08, 2022	SELL	$247.59 - $304.47 $8.25 Million - $10.1 Million	-33,310 Reduced 23.14%	110,660 $29.3 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $28 Million - $46.7 Million	143,970 New	143,970 $41.6 Million

Others Institutions Holding RGEN

# of Institutions

526

Shares Held

59.2M

Call Options Held

321K

Put Options Held

667K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Repligen Corp Transaction History